NEWARK, Del, Aug. 09, 2023 (GLOBE NEWSWIRE) -- The global Mammography Market was worth US$ 1,741.2 million in 2022 and is expected to be worth US$ 1,880.2 Million in 2023. The mammography market is expected to grow at a CAGR of 10.1% between 2023 and 2033, with a total value of US$ 4,899.7 Million by 2033.
Growing geriatric people, proactive drives by clinical consideration relationship to expose issues about early recognizable proof of breast malignant growth, and an upsurge in event speed of breast disease might drive the market growth.
Get your Sample Report copy and uncover an overview of the Mammography Market: https://www.futuremarketinsights.com/reports/sample/rep-gb-9040
Improved reimbursement in insurance policies, with extension in government funding for breast disease research, and mechanical degrees of progress fuel the market growth.
The Mammography Market faces challenges such as the high cost of advanced equipment, accessibility issues in certain regions, and concerns about radiation exposure. Efforts are being made to address these challenges through technological innovation, cost-effective solutions, and awareness campaigns. As the demand for accurate and reliable breast cancer screening methods continues to rise, the Mammography Market is expected to witness ongoing growth and advancements in both developed and developing regions.
Key Takeaways from this Market Study:
- The anticipated size of the Mammography Market in 2018 was US$ 1,260.8 million.
- The global Mammography Market expanded at a CAGR of 6.7% between 2018 and 2022.
- North America is projected to continue its dominance with a market share of 36.7%.
- Europe is predicted to secure a market share of 28.1%.
- Based on technology, the digital technology segment dominates the market with a market share of 63.4% in 2022.
- Under the end-user segment, hospitals dominated the end-use segment in 2022 with a share of around 47.3%.
Empower Your Business Strategy, get only specific data that matters to your business: https://www.futuremarketinsights.com/customization-available/rep-gb-9040
“Rise in technological advancements is one of the key drivers of the mammography market,” - comments an analyst at Future Market Insights (FMI).
Competitive Landscape:
Leading players are continuously innovating for developing novel diagnostic products with enhanced features and minimum side effects. Besides this, they are adopting growth strategies such as partnerships, acquisitions, collaborations, spending on awareness campaigns, etc. to gain a competitive edge in the market.
- Carestream Health unveiled new, innovative, and feature-rich medical imaging technologies that helped in boosting both patient and provider experience as well as improved diagnostic confidence while helping facilities to stay within budget at The Association for Medical Imaging Management (AHRA).
- Carestream Health announced that it had taken a planned next step to implement the previously announced recapitalization process with its lenders by voluntarily filing for reorganization under Chapter 11 of the United States Bankruptcy Code in the United States Bankruptcy Court for the District of Delaware.
Key Companies Profiled
- Allengers Medical Systems Limited
- FUJIFILM Holdings America Corporation
- Hologic, Inc.
- PLANMED OY
- Konica Minolta, GENERAL ELECTRIC, Inc.
- Siemens Healthcare Private Limited
- Carestream Health
- GE Healthcare
- Koninklijke Philips N.V.
- BET Medical.
Market Segmentation:
By Product Type:
- Breast Tomosynthesis
- Film Screen Systems
- X-Ray
- Others
By Technology Type:
- Digital
- Analog
- 3-D
- 2-D
By End Use:
- Hospitals
- Special Clinics
- Diagnosis Centers
- Ambulatory Surgical Centers
- Educational & Research Institutes
By Region:
- North America
- Latin America
- Western Europe
- Eastern Europe
- Asia Pacific excluding Japan
- Japan
- The Middle East & Africa
Uncover Market Secrets through Mammography Market Share Analysis - Don't Miss Out on Exclusive Discounts, Buy Today: https://www.futuremarketinsights.com/checkout/9040
Explore Future Market Insights, Inc. Extensive Coverage in Healthcare Market Domain:
Healthcare Interoperability Solutions Market: The global healthcare interoperability solutions market is forecasted to expand at 14.5% CAGR to reach a market valuation of US$ 16.2 billion by the end of 2033, up from US$ 3.7 billion which was recorded for 2022.
Healthcare Regulatory Affairs Outsourcing Market: The healthcare regulatory affairs outsourcing market is expected to grow at a CAGR of 11.3% during the forecast period. The market is valued at US$ 2 billion as of 2023, and by 2033, the market is expected to hit a valuation of US$ 5.8 billion.
Medical Hyperspectral Imaging Market: Expanding at a CAGR of 6.2%, the global medical hyperspectral imaging market is projected to increase from a valuation of US$ 181.8 Million in 2022 to US$ 294.7 Million by the end of 2030.
Portable Medical Devices Market: The global portable medical devices market is projected to expand at a CAGR of 10.7% during the forecast period. The market is estimated to generate market revenue of US$ 163.84 billion by 2033, increasing from US$ 59.28 billion in 2023.
Electronic Medical Records (EMR) Market: The global electronic medical records (EMR) market size is estimated to be valued at US$ 17.6 billion in 2023 and is projected to surpass a valuation of US$ 32.3 billion by 2033
Medical Automation Market: The global medical automation market size is expected to surpass an impressive valuation of US$ 44.45 billion in 2022 and is projected to exhibit a compound annual growth rate (CAGR) of 10.6% from 2023 to 2033.
Optical Imaging Market: The optical imaging market is anticipated to rise at a stable CAGR of 10.8% during the forecast period.
Medical Bed Market: Increasing investment in medical infrastructure is predicted to increase the worldwide medical bed market from US$ 3.4 Billion in 2022 to US$ 5.5 Billion in 2032. The medical bed market is expected to expand by 4.9% from 2022 to 2032.
Medical X-Ray Detectors Market: Expanding at a CAGR of 5.7%, the global medical X-Ray detectors market is expected to increase from a valuation of US$ 2.2 Billion in 2022 to US$ 3.2 Billion by 2029.
Breast Cancer Screening Tests Market: The global breast cancer screening tests market was valued at US$ 1.9 Billion in 2022 and is expected to reach US$ 4.4 Billion by 2033.
About Future Market Insights (FMI):
Future Market Insights, Inc. (ESOMAR certified, Stevie Award - recipient market research organization, and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favour the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10 years.
Contact Us:
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware - 19713, USA
T: +1-845-579-5705
LinkedIn | Twitter | Blogs | YouTube
For Sales Enquiries: sales@futuremarketinsights.com
